Skip Navigation

Cardiovascular Research 2001 49(3):568-581; doi:10.1016/S0008-6363(00)00268-6
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zachary, I.
Right arrow Articles by Gliki, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zachary, I.
Right arrow Articles by Gliki, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family

Ian Zachary* and Georgia Gliki

Centre for Cardiovascular Biology and Medicine, Department of Medicine, University College London, 5 University Street, London WC1E 6JJ, UK

* Corresponding author. Tel.: +44-20-7679-6620; fax: +44-20-7679-6212 i.zachary{at}ucl.ac.uk

The central role of vascular endothelial growth factor (VEGF) in angiogenesis in health and disease makes it attractive both as a therapeutic target for anti-angiogenic drugs and as a pro-angiogenic cytokine for the treatment of ischaemic heart disease. While VEGF binds to two receptor protein tyrosine kinases, VEGFR1 (Flt-1) and VEGFR2 (KDR), most biological functions of VEGF are mediated via VEGFR2, and the role of VEGFR1 is currently unknown. Neuropilin-1, a non-tyrosine kinase transmembrane molecule, may function as a co-receptor for VEGFR2. Considerable progress has recently been made towards delineating the signal transduction pathways distal to activation of VEGFR2. Activation of the mitogen-activated protein kinase, protein kinase C and Akt pathways are all strongly implicated in mediating diverse cellular biological functions of VEGF, including cell survival, proliferation, the generation of nitric oxide and prostacyclin and angiogenesis. Upregulation of metalloproteinases, activation of focal adhesion kinase and interactions between VEGF receptors and integrins are strongly implicated in VEGF-induced endothelial cell migration. Recent findings suggest important roles for the vasodilators nitric oxide and prostacyclin, in linking post-receptor signaling networks to downstream biological effects and in mediating some in vivo endothelial functions of VEGF.

KEYWORDS bFGF, basic fibroblast growth factor (FGF-2); eNOS, endothelial constitutive nitric oxide synthase; ERK, extracellular signal-regulated kinase; FAK, focal adhesion kinase; HUVEC, human umbilical vein endothelial cell; PGI2, prostacyclin; PKC, protein kinase C; VEGF, vascular endothelial growth factor A; VSMC, vascular smooth muscle cell; vWF, von Willebrand factor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
P. Gao, F. Shen, R. A. Gabriel, D. Law, E. Yang, G.-Y. Yang, W. L. Young, and H. Su
Attenuation of Brain Response to Vascular Endothelial Growth Factor-Mediated Angiogenesis and Neurogenesis in Aged Mice
Stroke, November 1, 2009; 40(11): 3596 - 3600.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. S. Facemire, A. B. Nixon, R. Griffiths, H. Hurwitz, and T. M. Coffman
Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
Hypertension, September 1, 2009; 54(3): 652 - 658.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. M. Jopling, A. F. Odell, N. M. Hooper, I. C. Zachary, J. H. Walker, and S. Ponnambalam
Rab GTPase Regulation of VEGFR2 Trafficking and Signaling in Endothelial Cells
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1119 - 1124.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Baker, S. J. O'Meara, M. Scannell, P. Maderna, and C. Godson
Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
J. Immunol., March 15, 2009; 182(6): 3819 - 3826.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Hao, L. Wang, Z. J. Zhao, and H. Tang
Identification of Protein Kinase D2 as a Pivotal Regulator of Endothelial Cell Proliferation, Migration, and Angiogenesis
J. Biol. Chem., January 9, 2009; 284(2): 799 - 806.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
D. M. Birk, J. Barbato, L. Mureebe, and R. A. Chaer
Basic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation
Vascular and Endovascular Surgery, January 1, 2009; 42(6): 517 - 530.
[Abstract] [PDF]


Home page
Eur Heart JHome page
P. E. Westerweel, F. L.J. Visseren, G. R. Hajer, J. K. Olijhoek, I. E. Hoefer, P. de Bree, S. Rafii, P. A. Doevendans, and M. C. Verhaar
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy
Eur. Heart J., November 2, 2008; 29(22): 2808 - 2817.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. M. Chilian and Y. F. Pung
Vascular Endothelial Growth Factor and the Collateral Circulation: The Story Continues
Circ. Res., October 24, 2008; 103(9): 905 - 906.
[Full Text] [PDF]


Home page
Circ. Res.Home page
C. C. Hong, T. Kume, and R. T. Peterson
Role of Crosstalk Between Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathways in Artery-Vein Specification
Circ. Res., September 12, 2008; 103(6): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Janer, S. Andersson, C. Haglund, R. Karikoski, and P. Lassus
Placental Growth Factor and Vascular Endothelial Growth Factor Receptor-2 in Human Lung Development
Pediatrics, August 1, 2008; 122(2): 340 - 346.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Chetty, S. S. Lakka, P. Bhoopathi, S. Kunigal, R. Geiss, and J. S. Rao
Tissue Inhibitor of Metalloproteinase 3 Suppresses Tumor Angiogenesis in Matrix Metalloproteinase 2-Down-regulated Lung Cancer
Cancer Res., June 15, 2008; 68(12): 4736 - 4745.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Sarkar, D. Chakroborty, U. R. Chowdhury, P. S. Dasgupta, and S. Basu
Dopamine Increases the Efficacy of Anticancer Drugs in Breast and Colon Cancer Preclinical Models
Clin. Cancer Res., April 15, 2008; 14(8): 2502 - 2510.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B.-J. Pyun, S. Choi, Y. Lee, T.-W. Kim, J.-K. Min, Y. Kim, B.-D. Kim, J.-H. Kim, T.-Y. Kim, Y.-M. Kim, et al.
Capsiate, a Nonpungent Capsaicin-Like Compound, Inhibits Angiogenesis and Vascular Permeability via a Direct Inhibition of Src Kinase Activity
Cancer Res., January 1, 2008; 68(1): 227 - 235.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. E. Jaalouk, M. G. Ozawa, J. Sun, J. Lahdenranta, R. O. Schlingemann, R. Pasqualini, and W. Arap
The Original Pathologische Anatomie Leiden-Endothelium Monoclonal Antibody Recognizes a Vascular Endothelial Growth Factor Binding Site within Neuropilin-1
Cancer Res., October 15, 2007; 67(20): 9623 - 9629.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Brownbill, G. C. McKeeman, J. C. Brockelsby, I. P. Crocker, and C. P. Sibley
Vasoactive and Permeability Effects of Vascular Endothelial Growth Factor-165 in the Term in Vitro Dually Perfused Human Placental Lobule
Endocrinology, October 1, 2007; 148(10): 4734 - 4744.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. E. Hoefer
Something is rotten in the state of angiogenesis -- H2S as gaseous stimulator of angiogenesis
Cardiovasc Res, October 1, 2007; 76(1): 1 - 2.
[Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Wagner and M. A. Q. Siddiqui
Signal Transduction in Early Heart Development (II): Ventricular Chamber Specification, Trabeculation, and Heart Valve Formation
Experimental Biology and Medicine, July 1, 2007; 232(7): 866 - 880.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wang, J. Chang, K.-D. Chen, S. Li, J. Y.-S. Li, C. Wu, and S. Chien
Selective adapter recruitment and differential signaling networks by VEGF vs. shear stress
PNAS, May 22, 2007; 104(21): 8875 - 8879.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. G. Ball, C. A. Shuttleworth, and C. M. Kielty
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors
J. Cell Biol., May 7, 2007; 177(3): 489 - 500.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Yin, K.-i. Morishige, T. Takahashi, K. Hashimoto, S. Ogata, S. Tsutsumi, K. Takata, T. Ohta, J. Kawagoe, K. Takahashi, et al.
Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo
Mol. Cancer Ther., May 1, 2007; 6(5): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Garcia Blanes, M. Oubaha, Y. Rautureau, and J.-P. Gratton
Phosphorylation of Tyrosine 801 of Vascular Endothelial Growth Factor Receptor-2 Is Necessary for Akt-dependent Endothelial Nitric-oxide Synthase Activation and Nitric Oxide Release from Endothelial Cells
J. Biol. Chem., April 6, 2007; 282(14): 10660 - 10669.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B. Angermayr, M. Fernandez, M. Mejias, J. Gracia-Sancho, J. C. Garcia-Pagan, and J. Bosch
NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats
Gut, April 1, 2007; 56(4): 560 - 564.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
J. D Chouhan, D. E Zamarripa, P. H Lai, C. U Oramasionwu, and J. L Grabinski
Sunitinib (Sutent(R)): A novel agent for the treatment of metastatic renal cell carcinoma
Journal of Oncology Pharmacy Practice, March 1, 2007; 13(1): 5 - 15.
[Abstract] [PDF]


Home page
Sci SignalHome page
R. E. Lamont and S. Childs
MAPping Out Arteries and Veins
Sci. Signal., October 3, 2006; 2006(355): pe39 - pe39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Mirzapoiazova, I. Kolosova, P. V. Usatyuk, V. Natarajan, and A. D. Verin
Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L718 - L724.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Chen, I. Amende, T. G. Hampton, Y. Yang, Q. Ke, J.-Y. Min, Y.-F. Xiao, and J. P. Morgan
Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1653 - H1658.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C.M. Mulders, M. C. Hendriks-Balk, M.-J. Mathy, M. C. Michel, A. E. Alewijnse, and S. L.M. Peters
Sphingosine Kinase-Dependent Activation of Endothelial Nitric Oxide Synthase by Angiotensin II
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2043 - 2048.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N. Schwarz, D. Renshaw, S. Kapas, and J. P Hinson
Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells.
J. Endocrinol., August 1, 2006; 190(2): 505 - 514.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. Su, Z. Cui, Z. Li, and E. R. Block
Calpain-2 regulation of VEGF-mediated angiogenesis
FASEB J, July 1, 2006; 20(9): 1443 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. M. Kim, K. E. Kim, G. Y. Koh, Y.-S. Ho, and K.-J. Lee
Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis.
Cancer Res., June 15, 2006; 66(12): 6167 - 6174.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Jia, A. Bagherzadeh, B. Hartzoulakis, A. Jarvis, M. Lohr, S. Shaikh, R. Aqil, L. Cheng, M. Tickner, D. Esposito, et al.
Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling
J. Biol. Chem., May 12, 2006; 281(19): 13493 - 13502.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. D. Covassin, J. A. Villefranc, M. C. Kacergis, B. M. Weinstein, and N. D. Lawson
Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish
PNAS, April 25, 2006; 103(17): 6554 - 6559.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. E. Battle, R. A. Lynch, and D. A. Frank
Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis.
Cancer Res., April 1, 2006; 66(7): 3649 - 3657.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Amino, Y. Ideyama, M. Yamano, S. Kuromitsu, K. Tajinda, K. Samizu, H. Hisamichi, A. Matsuhisa, K. Shirasuna, M. Kudoh, et al.
YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors
Clin. Cancer Res., March 1, 2006; 12(5): 1630 - 1638.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. H. Wu
Endothelial focal adhesions and barrier function
J. Physiol., December 1, 2005; 569(2): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Hu, J. Hofmann, and R. B. Jaffe
Phosphatidylinostol 3-Kinase Mediates Angiogenesis and Vascular Permeability Associated with Ovarian Carcinoma
Clin. Cancer Res., November 15, 2005; 11(22): 8208 - 8212.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. David-Dufilho, E. M.-V. Brussel, G. Topal, L. Walch, A. Brunet, and F. Rendu
Endothelial Thrombomodulin Induces Ca2+ Signals and Nitric Oxide Synthesis through Epidermal Growth Factor Receptor Kinase and Calmodulin Kinase II
J. Biol. Chem., October 28, 2005; 280(43): 35999 - 36006.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. D. D'Andrea, G. Iaccarino, R. Fattorusso, D. Sorriento, C. Carannante, D. Capasso, B. Trimarco, and C. Pedone
Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide
PNAS, October 4, 2005; 102(40): 14215 - 14220.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Toyota, D. C. Warltier, T. Brock, E. Ritman, C. Kolz, P. O'Malley, P. Rocic, M. Focardi, and W. M. Chilian
Vascular Endothelial Growth Factor Is Required for Coronary Collateral Growth in the Rat
Circulation, October 4, 2005; 112(14): 2108 - 2113.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Elsheikh, M. Uzunel, Z. He, J. Holgersson, G. Nowak, and S. Sumitran-Holgersson
Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity
Blood, October 1, 2005; 106(7): 2347 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Roviezzo, S. Tsigkos, A. Kotanidou, M. Bucci, V. Brancaleone, G. Cirino, and A. Papapetropoulos
Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 738 - 744.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Mac Gabhann and A. S. Popel
Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2851 - H2860.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
H. J. Knot, I. Laher, E. A. Sobie, S. Guatimosim, L. Gomez-Viquez, H. Hartmann, L.-S. Song, W.J. Lederer, W. F. Graier, R. Malli, et al.
Twenty Years of Calcium Imaging: Cell Physiology to Dye For
Mol. Interv., April 1, 2005; 5(2): 112 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. H Wu, S. Y Yuan, and H. J Granger
The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules
J. Physiol., February 15, 2005; 563(1): 95 - 104.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen
The biology of vascular endothelial growth factors
Cardiovasc Res, February 15, 2005; 65(3): 550 - 563.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. H. Annex and M. Simons
Growth factor-induced therapeutic angiogenesis in the heart: protein therapy
Cardiovasc Res, February 15, 2005; 65(3): 649 - 655.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. M. Short, A. Derrien, R. P. Narsimhan, J. Lawler, D. E. Ingber, and B. R. Zetter
Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by {beta}1 integrins
J. Cell Biol., February 14, 2005; 168(4): 643 - 653.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. J. Hicklin and L. M. Ellis
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
B. Reinhardt, P. Schaarschmidt, A. Bossert, A. Luske, G. Finkenzeller, T. Mertens, and D. Michel
Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus
J. Gen. Virol., January 1, 2005; 86(1): 23 - 30.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Y. Abadie, F. Bregeon, L. Papazian, F. Lange, B. Chailley-Heu, P. Thomas, P. Duvaldestin, S. Adnot, B. Maitre, and C. Delclaux
Decreased VEGF concentration in lung tissue and vascular injury during ARDS
Eur. Respir. J., January 1, 2005; 25(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamauchi, Y. Nishimura, S. Shigematsu, Y. Takeuchi, J. Nakamura, T. Aizawa, and K. Hashizume
Vascular Endothelial Cell Growth Factor Attenuates Actions of Transforming Growth Factor-{beta} in Human Endothelial Cells
J. Biol. Chem., December 31, 2004; 279(53): 55104 - 55108.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
R. L. Yauch, E. E. Kadel III, C. Nicholas, S. Tetangco, and D. O. Clary
Transcriptional-Based Screens for Pathway-Specific, High-Throughput Target Discovery in Endothelial Cells
J Biomol Screen, December 1, 2004; 9(8): 704 - 711.
[Abstract] [PDF]


Home page
J. Histochem. Cytochem.Home page
C.N. Mowa, S. Jesmin, I. Sakuma, S. Usip, H. Togashi, M. Yoshioka, Y. Hattori, and R. Papka
Characterization of Vascular Endothelial Growth Factor (VEGF) in the Uterine Cervix over Pregnancy: Effects of Denervation and Implications for Cervical Ripening
J. Histochem. Cytochem., December 1, 2004; 52(12): 1665 - 1674.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Q. Zhao, K. Egashira, K.-i. Hiasa, M. Ishibashi, S. Inoue, K. Ohtani, C. Tan, M. Shibuya, A. Takeshita, and K. Sunagawa
Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2284 - 2289.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Bagli, M. Stefaniotou, L. Morbidelli, M. Ziche, K. Psillas, C. Murphy, and T. Fotsis
Luteolin Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis; Inhibition of Endothelial Cell Survival and Proliferation by Targeting Phosphatidylinositol 3'-Kinase Activity
Cancer Res., November 1, 2004; 64(21): 7936 - 7946.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Sarkar, D. Chakroborty, R. B. Mitra, S. Banerjee, P. S. Dasgupta, and S. Basu
Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1554 - H1560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Le Boeuf, F. Houle, and J. Huot
Regulation of Vascular Endothelial Growth Factor Receptor 2-mediated Phosphorylation of Focal Adhesion Kinase by Heat Shock Protein 90 and Src Kinase Activities
J. Biol. Chem., September 10, 2004; 279(37): 39175 - 39185.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. J. Armstrong and J. Bischoff
Heart Valve Development: Endothelial Cell Signaling and Differentiation
Circ. Res., September 3, 2004; 95(5): 459 - 470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Cheng, H. Jia, M. Lohr, A. Bagherzadeh, D. I. R. Holmes, D. Selwood, and I. Zachary
Anti-chemorepulsive Effects of Vascular Endothelial Growth Factor and Placental Growth Factor-2 in Dorsal Root Ganglion Neurons Are Mediated via Neuropilin-1 and Cyclooxygenase-derived Prostanoid Production
J. Biol. Chem., July 16, 2004; 279(29): 30654 - 30661.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. A. Nordal, A. Nagy, M. Pintilie, and C. S. Wong
Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury: A Role for Vascular Endothelial Growth Factor
Clin. Cancer Res., May 15, 2004; 10(10): 3342 - 3353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Wu, Q. Zhang, D. K. Ann, A. Akhondzadeh, H. S. Duong, D. V. Messadi, and A. D. Le
Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C905 - C912.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-K. Min, K.-Y. Han, E.-C. Kim, Y.-M. Kim, S.-W. Lee, O.-H. Kim, K.-W. Kim, Y. S. Gho, and Y.-G. Kwon
Capsaicin Inhibits in Vitro and in Vivo Angiogenesis
Cancer Res., January 15, 2004; 64(2): 644 - 651.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S Battersby, H O D Critchley, A J de Brum-Fernandes, and H N Jabbour
Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle
Reproduction, January 1, 2004; 127(1): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Mac Gabhann and A. S. Popel
Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H153 - H164.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. H Wu, M. Guo, S. Y Yuan, and H. J Granger
Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor
J. Physiol., November 1, 2003; 552(3): 691 - 699.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
M. E. Olah and C. C. Caldwell
Adenosine Receptors and Mammalian Toll-Like Receptors: Synergism in Macrophages
Mol. Interv., October 1, 2003; 3(7): 370 - 374.
[Abstract] [Full Text]


Home page
BloodHome page
R. Salcedo, X. Zhang, H. A. Young, N. Michael, K. Wasserman, W.-H. Ma, M. Martins-Green, W. J. Murphy, and J. J. Oppenheim
Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells
Blood, September 15, 2003; 102(6): 1966 - 1977.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Benndorf, R. H. Boger, S. Ergun, A. Steenpass, and T. Wieland
Angiotensin II Type 2 Receptor Inhibits Vascular Endothelial Growth Factor-Induced Migration and In Vitro Tube Formation of Human Endothelial Cells
Circ. Res., September 5, 2003; 93(5): 438 - 447.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y.-B. Shui, X. Wang, J. S. Hu, S.-P. Wang, C. M. Garcia, J. D. Potts, Y. Sharma, and D. C. Beebe
Vascular Endothelial Growth Factor Expression and Signaling in the Lens
Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3911 - 3919.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. J. Giles, A. T. Stopeck, L. R. Silverman, J. E. Lancet, M. A. Cooper, A. L. Hannah, J. M. Cherrington, A.-M. O'Farrell, H. A. Yuen, S. G. Louie, et al.
SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes
Blood, August 1, 2003; 102(3): 795 - 801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Larrivee, D. R. Lane, I. Pollet, P. L. Olive, R. K. Humphries, and A. Karsan
Vascular Endothelial Growth Factor Receptor-2 Induces Survival of Hematopoietic Progenitor Cells
J. Biol. Chem., June 6, 2003; 278(24): 22006 - 22013.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. D. Lawson, J. W. Mugford, B. A. Diamond, and B. M. Weinstein
phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development
Genes & Dev., June 1, 2003; 17(11): 1346 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nakao, T. Kuwano, T. Ishibashi, M. Kuwano, and M. Ono
Synergistic Effect of TNF-{alpha} in Soluble VCAM-1-Induced Angiogenesis Through {alpha}4 Integrins
J. Immunol., June 1, 2003; 170(11): 5704 - 5711.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Louzier, B. Raffestin, A. Leroux, D. Branellec, J. M. Caillaud, M. Levame, S. Eddahibi, and S. Adnot
Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L926 - L937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Duval, S. Bedard-Goulet, C. Delisle, and J.-P. Gratton
Vascular Endothelial Growth Factor-dependent Down-regulation of Flk-1/KDR Involves Cbl-mediated Ubiquitination: CONSEQUENCES ON NITRIC OXIDE PRODUCTION FROM ENDOTHELIAL CELLS
J. Biol. Chem., May 23, 2003; 278(22): 20091 - 20097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Johnson, Y. M. Lee, T. L. Sander, E. Rabkin, F. J. Schoen, S. Kaushal, and J. Bischoff
NFATc1 Mediates Vascular Endothelial Growth Factor-induced Proliferation of Human Pulmonary Valve Endothelial Cells
J. Biol. Chem., January 10, 2003; 278(3): 1686 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
K. D. Miller, C. J. Sweeney, and G. W. Sledge
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era
Ann. Onc., January 1, 2003; 14(1): 20 - 28.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
H. Y. Shin, M. L. Smith, K. J. Toy, P. M. Williams, R. Bizios, and M. E. Gerritsen
VEGF-C mediates cyclic pressure-induced endothelial cell proliferation
Physiol Genomics, December 3, 2002; 11(3): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. M. Hazzard, F. Xu, and R. L. Stouffer
Injection of Soluble Vascular Endothelial Growth Factor Receptor 1 into the Preovulatory Follicle Disrupts Ovulation and Subsequent Luteal Function in Rhesus Monkeys
Biol Reprod, October 1, 2002; 67(4): 1305 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. C Wanstall, A. Gambino, T. K Jeffery, M. M Cahill, D. Bellomo, N. K Hayward, and G. F Kay
Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension
Cardiovasc Res, August 1, 2002; 55(2): 361 - 368.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Li, A. K. Ogasawara, R. Yang, W. Wei, G.-W. He, T. F. Zioncheck, S. Bunting, A. M. de Vos, and H. Jin
KDR (VEGF Receptor 2) Is the Major Mediator for the Hypotensive Effect of VEGF
Hypertension, June 1, 2002; 39(6): 1095 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Bogin and H. Degani
Hormonal Regulation of VEGF in Orthotopic MCF7 Human Breast Cancer
Cancer Res., April 1, 2002; 62(7): 1948 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Vincent, C. Soria, F. Mirshahi, P. Opolon, Z. Mishal, J.-P. Vannier, J. Soria, and L. Hong
Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 623 - 629.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Yang, A. K. Ogasawara, T. F. Zioncheck, Z. Ren, G.-W. He, G. G. DeGuzman, N. Pelletier, B.-Q. Shen, S. Bunting, and H. Jin
Exaggerated Hypotensive Effect of Vascular Endothelial Growth Factor in Spontaneously Hypertensive Rats
Hypertension, March 1, 2002; 39(3): 815 - 820.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Thuringer, L. Maulon, and C. Frelin
Rapid Transactivation of the Vascular Endothelial Growth Factor Receptor KDR/Flk-1 by the Bradykinin B2 Receptor Contributes to Endothelial Nitric-oxide Synthase Activation in Cardiac Capillary Endothelial Cells
J. Biol. Chem., January 11, 2002; 277(3): 2028 - 2032.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Vincent, C. Soria, F. Mirshahi, P. Opolon, Z. Mishal, J.-P. Vannier, J. Soria, and L. Hong
Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 623 - 629.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.